Overview
Hypereosinophilic syndrome is a disorder.
Auto-generated from clinical reference data. Not a substitute for medical advice.
Treatments & Interventions
Research Evidence
Peer-reviewed studies linked via MeSH term "Syndrome, Hypereosinophilic" from the MEDLINE/PubMed database.
Sort:
Parasitic-induced Loeffler's syndrome: A systematic review based on clinical reports.
[object Object], [object Object], [object Object] et al. · J Infect Public Health · 2026
PMID: 41161022Meta-Analysis
Efficacy of anti-interleukin 5 therapy in hypereosinophilic syndrome: An updated systematic review and meta-analysis.
[object Object], [object Object], [object Object] et al. · Allergy Asthma Proc · 2025
PMID: 40011991Meta-Analysis
Eosinophilic complications during dupilumab therapy for type 2 diseases: a systematic review.
[object Object], [object Object], [object Object] et al. · Rhinology · 2025
PMID: 40305840Meta-Analysis
What we have learned about lymphocytic variant hypereosinophilic syndrome: A systematic literature review.
[object Object], [object Object] · Clin Immunol · 2022
PMID: 35307610Meta-Analysis
Mepolizumab in Hypereosinophilic Syndrome: A Systematic Review and Meta-analysis.
[object Object], [object Object], [object Object] et al. · Clinics (Sao Paulo) · 2021
Treatment of lymphocyte-variant hypereosinophilic syndrome (L-HES): what to consider after confirming the elusive diagnosis.
[object Object], [object Object], [object Object] · Br J Haematol · 2021
PMID: 34105142Meta-Analysis
Endomyocardiofibrosis: A Systematic Review.
[object Object], [object Object], [object Object] et al. · Curr Probl Cardiol · 2021
PMID: 33418479Meta-Analysis
Gleich syndrome: a systematic review.
[object Object], [object Object], [object Object] et al. · Int J Dermatol · 2020
PMID: 32557651Meta-Analysis
Characterization of disease flares and impact of mepolizumab in patients with hypereosinophilic syndrome.
[object Object], [object Object], [object Object] et al. · Front Immunol · 2022
Association Between Baseline Therapy and Flare Reduction in Mepolizumab-Treated Patients With Hypereosinophilic Syndrome.
[object Object], [object Object], [object Object] et al. · Front Immunol · 2022
Search all PubMed articles for Hypereosinophilic syndrome
Research data from MEDLINE/PubMed
Quick Facts
- SNOMED CT
- 393573009
- UMLS CUI
- C1540912
- Fully Specified Name
- Hypereosinophilic syndrome (disorder)
- Specialists
- 0
- Diagnostic Biomarkers
- 0
- Known Treatments
- 9
Medical Disclaimer
This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.
Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.